All Stories

  1. Induced Pluripotent Stem Cells for Primary Ciliary Dyskinesia Modeling and Personalized Medicine
  2. Concise Review: Assessing the Genome Integrity of Human Induced Pluripotent Stem Cells: What Quality Control Metrics?
  3. Conservation/congélation des greffons de CSH dans un contexte pédiatrique : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
  4. Induced pluripotent stem cells: An unlimited source of organs for transplantation
  5. Human–animal chimeras: ethical issues about farming chimeric animals bearing human organs
  6. Human induced pluripotent stem cells: A disruptive innovation
  7. Les cellules souches pluripotentes induites : un nouveau paradigme pour l’étude des tissus humains
  8. Genome Editing and Dialogic Responsibility: “What's in a Name?”
  9. Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency
  10. Temporal Analysis of Genome Alterations Induced by Single-Cell Passaging in Human Embryonic Stem Cells
  11. Quality controls on cord blood unit contiguous segments: Recommendation of the SFGM-TC
  12. Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient
  13. Combining DGE and RNA-sequencing data to identify new polyA+ non-coding transcripts in the human genome
  14. Side Scatter Intensity Is Highly Heterogeneous in Undifferentiated Pluripotent Stem Cells and Predicts Clonogenic Self-Renewal
  15. La reprogrammation, un jeu de hasard ?
  16. Embryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective
  17. Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes
  18. Insights into human endometrial receptivity from transcriptomic and proteomic data
  19. Human Cumulus Cells Molecular Signature in Relation to Oocyte Nuclear Maturity Stage
  20. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state
  21. Characterization of a Transitional Preplasmablast Population in the Process of Human B Cell to Plasma Cell Differentiation
  22. Dissecting the First Transcriptional Divergence During Human Embryonic Development
  23. Transcriptome analysis reveals dialogues between human trophectoderm and endometrial cells during the implantation period
  24. Involvement of BCL2 family members in the regulation of human oocyte and early embryo survival and death: gene expression and beyond
  25. Benchmarking Human Pluripotent Stem Cell Markers During Differentiation into the Three Germ Layers Unveils A Striking Heterogeneity: All Markers are not Equal
  26. Erratum: Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription
  27. Analysis of replication profiles reveals key role of RFC-Ctf18 in yeast replication stress response
  28. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis
  29. Distinct Transcriptome Expression of the Temporal Cortex of the Primate Microcebus murinus during Brain Aging versus Alzheimer's Disease-Like Pathology
  30. Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applications
  31. 1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma
  32. Human cumulus cells as biomarkers for embryo and pregnancy outcomes
  33. Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
  34. Expression Map of the Human Exome in CD34+ Cells and Blood Cells: Increased Alternative Splicing in Cell Motility and Immune Response Genes
  35. Human pluripotent stem cells: From biology to cell therapy
  36. Controlled Ovarian Hyperstimulation for In Vitro Fertilization Alters Endometrial Receptivity in Humans: Protocol Effects
  37. Correlating Global Gene Regulation to Angiogenesis in the Developing Chick Extra-Embryonic Vascular System
  38. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization
  39. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription
  40. P53, ARF et P16 : la ligne Maginot de la reprogrammation cellulaire
  41. Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis
  42. LH/hCGR gene expression in human cumulus cells is linked to the expression of the extracellular matrix modifying gene TNFAIP6 and to serum estradiol levels on day of hCG administration
  43. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
  44. Les cellules souches embryonnaires humaines : de la transgression de l’embryon humain à la médecine régénératrice de demain
  45. Embryonic stem cell markers expression in cancers
  46. Cellules souches pluripotentes de rat :so what ?
  47. Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells
  48. Induction of angiogenesis by normal and malignant plasma cells
  49. APRIL is overexpressed in cancer: link with tumor progression
  50. Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients
  51. C/EBPA methylation is common in T-ALL but not in M0 AML
  52. Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma
  53. A gene expression signature shared by human mature oocytes and embryonic stem cells
  54. A non-invasive test for assessing embryo potential by gene expression profiles of human cumulus cells: a proof of concept study
  55. Identification of new biomarkers of human endometrial receptivity in the natural cycle
  56. Des cellules souches au gamète mâle : science-fiction ou avenir proche ?
  57. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase
  58. Qualité ovocytaire et embryonnaire : les marqueurs apoptotiques ont-ils leur place dans le potentiel préimplantatoire ?
  59. Les marqueurs apoptotiques ont-ils leur place comme marqueurs potentiels de l’exploration de l’infertilité masculine ?
  60. CD200: A putative therapeutic target in cancer
  61. Transcriptome of retrovirally transduced CD8+ lymphocytes: Influence of cell activation, transgene integration, and selection process
  62. Total fertilization failure and molecular abnormalities in metaphase II oocytes
  63. A new method for class prediction based on signed-rank algorithms applied to Affymetrix® microarray experiments
  64. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma
  65. Input of DNA Microarrays to Identify Novel Mechanisms in Multiple Myeloma Biology and Therapeutic Applications
  66. Targeting NF-κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth
  67. TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines
  68. Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
  69. A Meta-Analysis of Human Embryonic Stem Cells Transcriptome Integrated into a Web-Based Expression Atlas
  70. Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Prognosis Value Determined by Microarray Analysis
  71. Identifying new human oocyte marker genes: a microarray approach
  72. CD200 is a new prognostic factor in multiple myeloma
  73. Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes
  74. Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
  75. Microarray-based understanding of normal and malignant plasma cells
  76. The human cumulus-oocyte complex gene-expression profile
  77. Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes
  78. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature
  79. Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells
  80. An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis
  81. Comparison of Murine Leukemia Virus, Human Immunodeficiency Virus, and Adeno-Associated Virus Vectors for Gene Transfer in Multiple Myeloma: Lentiviral Vectors Demonstrate a Striking Capacity to Transduce Low-Proliferating Primary Tumor Cells
  82. Survival and Proliferation Factors of Normal and Malignant Plasma Cells
  83. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells
  84. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation
  85. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays
  86. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells
  87. Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays
  88. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1
  89. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells
  90. Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors
  91. Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb.